iifl-logo

Strides Pharma Science Ltd Dividend

666.75
(-0.37%)
Apr 1, 2025|12:00:00 AM

Strides Pharma CORPORATE ACTIONS

02/04/2024calendar-icon
02/04/2025calendar-icon
PurposeAnnouncement DateEx-DateRecord DateDividend AmountDividend per ShareRemark
Dividend22 May 20249 Sep 20249 Sep 20242.525Final
The Board of Directors at their meeting held today i.e., on May 22, 2024. Recommendation of final dividend of Rs. 2.50/- per equity share of Rs. 10/- each (at the rate of 25%) for financial year ended March 31, 2024. Intimation of Record Date for the purpose of Final Dividend for FY24 Record Date for the purpose of said Dividend is Monday, September 9, 2024. Dividend once approved by the Members in the ensuing AGM, shall be paid within 30 days from the date of such approval (As Per BSE Announcement dated on 22.08.2024)

Strides Pharma: Related News

Strides Pharma Q3 Profit at ₹90 Crore, Revenue Up 15%
31 Jan 2025|11:55 AM

EBITDA grew 48% YoY at ₹210 crore, from ₹142 crore in the same quarter last year, marking better profitability.

Read More
Strides Pharma Posts ₹93 Crore Q2 Profit
28 Oct 2024|05:13 PM

EBITDA rose significantly to ₹235.7 Crore, a 54% increase from ₹153 Crore in the corresponding period of the previous year.

Read More
Strides Pharma gets shareholders’ approval for CDMO unit
11 Sep 2024|03:17 PM

In September 2023, the pharmaceutical behemoth revealed OneSource. The stock exchanges approved the idea earlier this year, in May.

Read More
Strides gets US FDA nod for Theophylline tablets
6 Sep 2024|12:18 PM

The medication is bioequivalent and therapeutically equivalent to Schering Corp's Reference Listed Drug (RLD), THEO-DUR.

Read More
Strides Pharma's Chennai Facility Receives USFDA Approval
19 Aug 2024|03:21 PM

The Alathur facility is key to Strides' global operations, especially in the US and other regulated markets, specializing in the production of tablets and capsules.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.